Company intelligence / Profile preview

Allife Medical Science and Technology

Beijing, Beijing, Chinacrisprmedicinenews.com ↗

Ownership: Private
Employees: ~190
Development stage: Phase 1

Overview

Allife Medical Science and Technology is a clinical-stage biotech company specializing in next-generation cellular therapies using iPSC technology, CAR-NK platforms, and CRISPR gene editing. The company has achieved first-in-China clinical approvals for its CAR-NK cell therapy targeting ovarian cancer and an iPSC-derived endothelial progenitor cell therapy for acute ischemic stroke. Its lead program ALLLIFE CAR-NK CD19 is currently in Phase II trials for B-cell leukemia. The company operates as a platform innovator with a broad pipeline across oncology and regenerative medicine indications.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: Cellular therapies (CAR-NK cells, iPSC-derived cell therapies)Gene editing (CRISPR-Cas9)Induced pluripotent stem cells (iPSC)
Industry: Biotech

Drug pipeline

14 assets

anti-CD22 CAR NK cells

13 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Allife Medical Science and Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allife Medical Science and Technology.

Explore the full profile